Pre-eclampsia - a disease of oxidative stress resulting from the catabolism of DNA (primarily fetal) to uric acid by xanthine oxidase in the maternal liver: A hypothesis

Bioscience Hypotheses

Volumn 1, Issue 1, 2008, Pages 35-43

  McMaster Fay, Roger A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Fetal DNA; Oxidative stress; Pre eclampsia; Uric acid; Xanthine oxidase

Indexed keywords

ASPARTATE AMINOTRANSFERASE; DNA; ISOENZYME; POLYUNSATURATED FATTY ACID; PURINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; URIC ACID; XANTHINE OXIDASE;

ARTICLE; CATABOLISM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPERURICEMIA; HYPOTHESIS; IMAGE ANALYSIS; LIPID PEROXIDATION; LIPID STORAGE; LIVER CELL; LIVER CELL DAMAGE; LIVER FUNCTION TEST; LUNG CIRCULATION; MATERNAL BLOOD; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PLACENTA CIRCULATION; PREECLAMPSIA; PROTEIN BLOOD LEVEL; TROPHOBLAST; VENOUS CIRCULATION;

EID: 48349086915     PISSN: 17562392     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bihy.2008.01.002     Document Type: Article

References (60)

1. Wu X.W., Muzny D.M., Lee C.C., and Caskey C.T. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol 34 (1992) 78-84
2. In: Hughes E.C. (Ed). Obstetrics - gynaecologic terminology (1972), FA Davis, Philadelphia 422-423
3. Davey D.A., and MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158 (1998) 892-898
4. Redman C.W.G., and Jefferies M. Revised definition of pre-eclampsia. Lancet 331 (1988) 809-812
5. Redman C.W.G., Beilin L.J., Bonnar J., and Wilkinson R.H. Plasma urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 307 (1976) 1370-1373
6. Roberts J.M., Bodnar L.M., Lain K.Y., Hubel C.A., Markovic N., Ness R.B., et al. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 46 (2005) 1263-1269
7. Yassaee F. Hyperuricemia and perinatal outcomes in patients with severe pre-eclampsia. Iran J Med Sci 28 (2003) 198-199
8. Fay R.A., Ellwood D.A., Bruce S., and Turner A. Colour Doppler imaging of the uteroplacental circulation in the middle trimester: observations on the development of a low resistance circulation. Ultrasound Obstet Gynecol 4 (1994) 391-395
9. Fay R.A., Ellwood D.A., Bruce S., and Turner A. Colour Doppler imaging of the uteroplacental circulation in the mid-trimester: features of the uterine artery flow velocity waveform that predict abnormal pregnancy outcome. Aust N Z J Obstet Gynaecol 34 (1994) 515-519
10. Fay R.A. Uric acid in pregnancy and preeclampsia: an alternative hypothesis. Aust N Z J Obstet Gynaecol 30 (1990) 141-142
11. Attwood H.D., and Park W.W. Embolisation to the lung by trophoblast. BJOG 68 (1961) 611-617
12. Knight M., Redman C.W.G., Linton E.A., and Sargent I.L. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. BJOG 105 (1998) 632-640
13. Pijnenborg R., Robertson W.B., Brosens I., and Dixon H.G. Trophoblast migration and the establishment of the hemochorial placentation in man and laboratory animals. Placenta 2 (1981) 71-92
14. Zhong X.Y., Laivuori H., Livingston J.C., Ylikorkala O., Sibai B., Holzgreve W., et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 184 (2001) 414-419
15. Levine R.J., Qian C., LeShane E.S., Yu K.F., England L.J., Schisterman E.F., et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of pre-eclampsia. Am J Obstet Gynecol 190 (2004) 707-713
16. Berry C.E., and Hare J.M. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555 3 (2004) 589-606
17. Chesley L.C. Diagnosis of preeclampsia. Obstet Gynecol 65 3 (1985 March) 423-425
18. Fadel H.E., Sabour M.S., Mahran M., Seif E., and Mahallawi M.N. Serum uric acid in pre-eclampsia and eclampsia. J Egypt Med Assoc 52 (1969) 12-23
19. Fadel H.E. In: Rippmann E.T. (Ed). Die Spätgestose (1970), Schwabe, Basel 28 Quoted in Hytten FE, Lind T. Diagnostic indices in pregnancy. Basel: Documenta Geigy; 1973. p. 50-1
20. Powers R.W., Bodnar L.M., Ness R.B., Cooper K.M., Gallaher M.J., Frank M.P., et al. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol 194 (2006) 160.e1-160.e8
21. Hayashi M., Ueda Y., Hosmimoto K., Ota Y., Fukasawa I., Sumori K., et al. Changes in urinary excretion of six biochemical parameters in normotensive pregnancy and preeclampsia. Am J Kidney Dis 39 2 (2002)
22. Remero R., Vizoso J., Emamian M., Duffy T., Riely C., Halford T., et al. Clinical significance of liver dysfunction in pregnancy-induced hypertension. Am J Perinatol 5 (1988) 146-151
23. Karabulut A.B., Kafkash A., Burak F., and Gozukara E.M. Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia. Cell Biochem Funct 23 (2005) 279-283
24. Ch'ng C.L., Morgan M., Hainsworth I., and Kingham J.G.C. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 51 (2002) 876-880
25. Minakami H., Oka N., Sato T., Tamada T., Yasuda Y., and Hirota N. Pre-eclampsia: a microvesicular fat disease of the liver?. Am J Obstet Gynecol 159 (1988) 1043-1047
26. Minakami H., Kimura K., Tamada T., Yasuda Y., and Hirota N. Hepatocellular lipofuscin in pre-eclampsia. Asia-Oceania J Obset Gynaecol 15 (1989) 277-280
27. Sies H. Oxidative stress: introductory remarks. In: Sies H. (Ed). Oxidative stress (1985), Academic Press, London 1-2
28. Weiss S.J. Oxygen, ischemia, and inflammation. Acta Physiol Scand 548 (1986) 9-37
29. Gupta S., Agarwal A., and Sharma R.K. The role of placental oxidative stress and lipid peroxidation in pre-eclampsia. Obstet Gynecol Surv 60 (2005) 807-816
30. Moretti M., Phillips M., Abouzeid A., Cataneo R.N., and Greenberg J. Increased breath markers of oxidative stress in normal pregnancy and in pre-eclampsia. Am J Obstet Gynecol 190 (2004) 1184-1190
31. Shaaraway M., Aref A., Salem E.M., and Sheiba M. Radical-scavenging antioxidants in pre-eclampsia and eclampsia. Int J Gynecol Obstet 60 (1998) 123-128
32. Karb S. Total free radical trapping antioxidant potential in pre-eclampsia. Int J Gynecol Obstet 69 (2000) 23-26
33. Harma M., Harma M., and Erel O. Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol 118 (2005) 47-51
34. Chappell L.C., Seed P.T., Briley A.L., Kelly FJ., Lee R., Hunt B.J., et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354 (1999) 810-816
35. Sacks G.P., Studena K., Sargent I.L., and Redman C.W. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 179 (1998) 80-86
36. Buttke T.M., and Sanderstrom P.A. Oxidative stress as a mediator of apoptosis. Immunol Today 15 (1994) 7-10
37. Del Maestro R.F., Björk J., and Arfors K.E. Increase in microvascular permeability induced by enzymatically generated free radicals. Microvasc Res 22 (1981) 239-254
38. Spargo B.H., McCartney C.P., and Winemiller R. Glomerular capillary endotheliosis in toxaemia of pregnancy. Arch Pathol 68 (1959) 593-599
39. Stubbs T.M., Lazarchick J., and Horger III E.O. Plasma fibronectin levels in pre-eclampsia: a possible biochemical marker for vascular endothelial damage. Am J Obstet Gynecol 150 (1984) 885-887
40. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., and McLaughlin M.K. Preeclampsia: an endothelial disorder. Am J Obstet Gynecol 161 (1989) 1200-1204
41. Belo L., Santos-Silva A., Rumley A., Lowe G., Pereira-Leite L., Quintanilha A., et al. Elevated tissue plasminogen activator as a potential marker of endothelial dysfunction in pre-eclampsia: correlation with proteinuria. BJOG 109 (2002) 1250-1255
42. Henrich W.L. Southwestern internal medicine conference: the endothelium - a key regulator of vascular tone. Am J Med Sci 302 (1991) 319-328
43. Gyglewski R.J., Palmer R.M.J., and Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320 (April 1986) 454-456
44. Gant N.F., Daley G.L., Chand S., Whalley P.J., and MacDonald P.C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 52 (1973) 2682-2689
45. Tulenko T., Schneider J., Floro C., and Sicilla M. The in vitro effect of arterial wall function of serum from patients with pregnancy-induced hypertension. Am J Obstet Gynecol 156 4 (1987) 817-823
46. Hubel C.A., McLaughlin M.K., Evans R.W., Hauth B.A., Sims C.J., and Roberts J.M. Fasting serum triglycerides, free fatty acids and malondialdehyde are increased in preeclampsia are positive correlated and decrease within 48 hours post partum. Am J Obstet Gynecol 174 (1996) 975-982
47. Roberts J.M., Taylor R.N., and Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 4 8 (1991) 700-708
48. Davidge S.T., Hubel C.A., Brayden R.D., Capeless E.C., and McLaughlin M.K. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol 79 6 (1992) 897-901
49. Many A., Hubel C.A., and Roberts J.M. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 174 1 (1996) 288-291
50. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
51. Goodman G., Rall T.W., Nies A.S., and Taylor P. Analgesic-antipyretics and antiinflammatory agents: drugs employed in the treatment of rheumatoid arthritis and gout. 8th ed. (1990), Pergamon Press, NY
52. Tálosi G., Nèmeth I., and Pintèr S. Inhibitory effects of methylxanthines on the pre-eclamptic-like symptoms in ewes. Eur J Obstet Gynecol Reprod Biol 99 (2001) 25-32
53. Farquharson C.A.J., Butler R., Hill A., Belch J.J.F., and Struthers A.D. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106 (2002) 221-226
54. Butler R., Morris A.D., Belch J.J.F., Hill A., and Struthers A.D. Allopurinol normalizes endothelial dysfunction in type 2 diabetes with mild hypertension. Hypertension 35 (2000) 746-751
55. Guthikonda S., Sinkey C., Barenz T., and Haynes W.G. Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation 107 (2003) 416-421
56. Oliva M.R., Mortele K.J., Segatto E., Glickman J.N., Erturk S.M., Ros P.R., et al. Computed tomography features of non-alcoholic steatohepatitis with histologic correlation. J Comput Assist Tomogr 30 (2006) 37-43
57. Davidson L.E., Kuk J.L., Church T.S., and Ross R. Protocol for measurement of liver fat by computed tomography. J Appl Physiol 100 (2006) 864-868
58. In: Lewis G. (Ed). Why mothers die 2000-2002 (2004), RCOG Press, London
59. Loudon I. Some historical aspects of toxaemia of pregnancy. Br J Obstet Gynaecol 98 (1991) 853-858
60. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. BJOG 99 (1992) 547-553